Barrons.com66d agobearish
Moderna’s Cancer Vaccine Rally Sparks Rare Sell Rating and Projected 45% Stock DropNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
109last 24h
3127last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
Insider Monkey66d agoneutral
This Fund Bought Moderna Before It Nearly Tripled. See Its 2 New Stock PicksInsider Monkey67d agoneutral
Jim Cramer Explains Why Heavily Shorted Moderna (MRNA) Has Room to RunSimply Wall St.67d agoneutral
US Stock Market Today: S&P 500 Futures Slip As Rising Yields Pressure EquitiesSimply Wall St.68d agoneutral
Did Merck’s (MRK) First Positive Phase 3 Individualized mRNA Cancer Trial Just Redefine Its Moat?Motley Fool68d agobullish
Down More Than 30% From Its Peak, Is Now the Perfect Time to Buy Sandisk Stock?24/7 Wall St.68d agoneutral
Moderna Rises 6% Despite GSK Moving Rival mRNA Flu Vaccine to Phase III24/7 Wall St.68d agobullish
Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story?Clinical Trials Arena68d agoneutral
GSK hopes to take on Moderna as it moves mRNA flu vaccine to Phase III trialMotley Fool68d agoneutral
Moderna Stock More Than Doubled in August. Is the Stock a Buy, a Hold, or a Sell?Insider Monkey69d agobullish
Moderna (MRNA) Soars 156% in August - Here’s What Propelled The RallyThe Wall Street Journal69d agoneutral
Stock Market Heads for August Gains - Thanks to Unusual WinnersInsider Monkey70d agoneutral
Jim Cramer Called Moderna Inc. (NASDAQ:MRNA) & Merck’s Trial Results EncouragingSimply Wall St.70d agoneutral
Merck (MRK) Posts First Positive Phase 3 Result For Personalized mRNA Melanoma TherapyInsider Monkey70d agoneutral
Healthcare’s Best Week Since June Traces Back to a Single Moderna and Merck Cancer TrialSimply Wall St.71d agoneutral
What Do Moderna (MRNA) FDA Vaccine Approvals Mean For Its Respiratory Push?24/7 Wall St.71d agoneutral
‘This Breakup Saved You Far More Than Moderna Ever Could’: Orman to Woman Dumped After 180% SpikeInsider Monkey72d agoneutral
Moderna (MRNA) Plans $2B of Zero-Coupon Convertible Debt. Is the Capped Call Enough to Control Dilution?The Wall Street Journal72d agoneutral
Pharma Industry Stares Down Biggest Patent Cliff in DecadesInsider Monkey72d agoneutral
Jim Cramer Says Hold on to Moderna (MRNA) After Phase 3 Cancer Trial